CFO Mark Livingston’s $0.00 RSU Purchase Signals Strong Management Confidence in Progyny’s Growth Trajectory
Progyny CFO’s 45,454‑share buy signals long‑term confidence amid near‑flat price, boosting investor sentiment for a rebound in fertility‑benefits growth.
3 minutes to read
